US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Endo International plc, et al.

Track this case

Case overview

Case Number:

7:22-bk-22549

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. July 20, 2023

    Endo International Wins More Support For $6B Ch. 11 Sale

    Bankrupt pharmaceutical company Endo International PLC told a New York judge Thursday that it has resolved objections from key stakeholders in its Chapter 11 case and garnered increased support for a $6 billion sale of its assets to a group of debtholders.

  2. July 19, 2023

    Endo Pitches Deal With Distributors Over Ch. 11 Sale Plan

    Bankrupt pharmaceutical company Endo International asked a New York bankruptcy court Tuesday to approve a settlement with distributors, manufacturers and pharmacies over indemnification of claims in opioid litigation that should remove an obstacle blocking the sale of Endo's assets.

  3. April 12, 2023

    Endo Gets OK For $27M Deal With Novavax In Contract Fight

    A New York bankruptcy judge on Wednesday gave Endo International permission to settle a contract dispute with COVID-19 vaccine maker Novavax for $27 million after the pharmaceutical company said Novavax may be heading for bankruptcy itself.

  4. January 19, 2023

    Endo Gets Approval For Fee Deal With State Governments

    A New York bankruptcy judge Thursday gave Endo International permission to pick up the professional fees for a group of states with claims against the pharmaceutical maker for its opioid sales, saying it's in the company's interest to make the payments.

  5. January 09, 2023

    Endo Ch. 11 Could Stiff Future Opioid Claimants, Judge Told

    Despite previous statements to the contrary, a proposed bankruptcy reorganization plan does not require embattled pharmaceutical company Endo International or any purchaser of its assets to establish a trust fund for future opioid victims, a future claims representative has argued.

  6. November 17, 2022

    Akin Gump Gets Green Light To Represent Endo Claimants

    A New York federal bankruptcy judge granted Endo International opioid claimants' bid to retain Akin Gump Strauss Hauer & Feld LLP attorneys in ongoing Chapter 11 proceedings, finding that U.S. Trustee's Office objections have been resolved, according to a filing entered Thursday.

  7. November 04, 2022

    Endo Claimants' Request To Hire Akin Gump Draws Objection

    The U.S. Trustee's Office objected to Endo International opioid claimants' retention of Akin Gump Strauss Hauer & Feld LLP attorneys in ongoing Chapter 11 proceedings Thursday, arguing that the firm represents a party with conflicting interests in the dispute.

  8. October 21, 2022

    Navient Collections Halted, Mallinckrodt Faces $1.6B Suit

    Navient Solutions is appealing a nationwide injunction barring it from collecting on certain student loans discharged through bankruptcy, Mallinckrodt creditors are suing for the return of $1.6 billion used to buy back shares pre-bankruptcy, and liquidators for crypto hedge fund Three Arrows Capital want to serve subpoenas via Twitter. This is the week in bankruptcy.

  9. October 19, 2022

    Endo Gets OK For Cash Use After Deal With Creditors

    A New York bankruptcy judge Wednesday gave Endo International approval to use the cash securing its loans after hearing it had made changes to the order in response to creditor complaints that the arrangement was too favorable to secured lenders.

  10. October 07, 2022

    Creditors Say Endo Cash Collateral Conditions Favor Lenders

    Unsecured creditors and opioid claimants in Endo International's Chapter 11 case are asking a New York bankruptcy judge to reject the pharmaceutical maker's request to use cash collateral, saying the proposal gives too much away to secured lenders.